National Centre for Cell Science, Pune, India.
National Centre for Cell Science, Pune, India
J Leukoc Biol. 2017 Feb;101(2):377-394. doi: 10.1189/jlb.1RU0716-327R. Epub 2016 Nov 29.
The intestinal epithelial lining is a very dynamic interface, where multiple interactions occur with the external world. The intestinal epithelial barrier is continuously exposed to a huge load of commensal microorganisms, food-borne antigens, as well as invading enteropathogens. Intestinal epithelial cells (IECs) and underlying immune cells are the main players in maintaining the delicate balance between gut tolerance and inflammation. IECs deferentially express the variety of chemokines and chemokine receptors, and these receptor-ligand interactions not only mediate the infiltration and activation of immune cells but also switch on the survival cascades in IECs. In this review, we discussed how chemokine-chemokine receptor-induced interactions play a central role to coordinate the interplay between IECs and gut immune cells to maintain homeostasis or elicit gut inflammation. Furthermore, we discussed how chemokines and chemokine receptors were used as a target for developing new drugs and therapies to control gut inflammation and autoimmunity.
肠上皮衬里是一个非常动态的界面,与外部世界发生多种相互作用。肠上皮屏障不断暴露于大量共生微生物、食物源性抗原以及入侵的肠道病原体。肠上皮细胞(IEC)和固有免疫细胞是维持肠道耐受和炎症之间微妙平衡的主要参与者。IEC 特异性表达多种趋化因子和趋化因子受体,这些受体-配体相互作用不仅介导免疫细胞的浸润和激活,还启动 IEC 中的存活级联反应。在这篇综述中,我们讨论了趋化因子-趋化因子受体诱导的相互作用如何发挥核心作用,以协调 IEC 和肠道免疫细胞之间的相互作用,从而维持稳态或引发肠道炎症。此外,我们还讨论了如何将趋化因子和趋化因子受体用作开发新药和治疗方法的靶点,以控制肠道炎症和自身免疫。